menuMenu
  • searchSEARCH
  • WORLDWIDE
  • CONTACT US
  • About Us
    close
    • About Us
    • Responsibility
    • Our Work
    • Leadership
      • – Board of Directors
      • – Executive Committee
    • Access to Investigational
    • Medicines
    • How We Operate
    • Corporate Responsibility
    • Our History
    • Our People
    • Featured Stories
  • Inventing For Life
    close
    • Inventing For Life
  • Research
    close
    • Research
    • Our People, Our Culture
    • Our R&D Process
    • What We're Working On
    • Pipeline
    • Clinical Trials
    • Invent with Us
  • Licensing
    close
    • Business Development & Licensing
    • BD&L Contacts
  • Media Center 
  • Careers
    close
    • Careers
    • Apply Now
    • What's Possible?
    • Why MSD ?
      • –Diversity At MSD
      • –Prepared for Launch
      • –Compensation and Benefits
    • How Will You Invent the Future?
  • About Us navigate_next
    • Responsibility
    • Corporate Responsibility
    • Our Worknavigate_next
    • Leadershipnavigate_next
      • Board of Directors
      • Executive Committee
    • Access to Investigational Medicines
    • How We Operate
    • Our History
    • Our People
    • Featured Stories
  • Inventing For Life 
  • Research navigate_next
    • Our People, Our Culture
    • Our R&D Process
    • What We're Working On
    • Pipeline
    • Clinical Trials
    • Invent with Us
  • Licensing navigate_next
    • Business Development & Licensing
    • BD&L Contacts
  • Newsroom navigate_next
    • Media Center
  • Careers navigate_next
    • Apply Now
    • What’s Possible?
    • Why MSD?navigate_next
      • Diversity At MSD
      • Prepared for Launch
      • Compensation and Benefits
    • How Will You Invent the Future?
  • Contact Us navigate_next

MSD – Inventing For Life

For more than a century, MSD, a leading global biopharmaceutical company, has been inventing for life, bringing forward medicines and vaccines for the world's most challenging diseases. MSD is a trade name of Merck & Co., Inc., with headquarters in Kenilworth, N.J., U.S.A. For more than 30 years, MSD Saudi Arabia has been preserving and improving human life by promoting access to medicines and vaccines and making these products available to all who need them.

LEARN MORE

 
 

MSD Saudi Arabia

Merck Sharp & Dohme, Saudi Arabia started its operation in the Kingdom in 1978, through its local distributors, MSD Saudi Arabia provides innovative products based on the highest level of scientific excellence including products for cardiovascular issues, asthma, pain and inflammation, osteoporosis, neurological issues, and ophthalmic pathological disorders, in addition to several specialized hospital products and vaccines

LEARN MORE

 
 

Univadis

Univadis is a comprehensive medical resource for the healthcare professional; if you're looking for quality, independent news, information, and learning programs online, explore Univadis and discover how it can help you stay informed.

LEARN MORE

 
 

The Drive for Innovation

Our resolve to apply scientific insight and cutting-edge technology to help tackle health challenges is inspired by the differences we strive to make in the lives of people around the world.

LEARN MORE

 
 

SOCIAL @MSDInvents
OTHER MSD SITES
 
 

We remain dedicated to helping those impacted by #HurricaneMaria and the #MexicoEarthquake. https://t.co/0gxTche5ia

We’re working to reduce our waste footprint to create a future w/ more beautiful land & less landfills:… https://t.co/SQknCRVUDu

“What a great day! I am a proud partner of Your Cancer Game Plan and have more tips to share with you. Visit:… https://t.co/HKSBq99bDz

    • Connect with Us:
 
 
  • OTHER MSD SITES
    MSD for Mothers
  • Corporate Responsibility
    MSD Corporate Responsibility website chevron_right
    Transparency Disclosures chevron_right
  • MSD Animal Health
  • MSD Manuals
  • Univadis (a service of MSD subsidiary Aptus Health)
  • MSD Middle East
 
 
 

Copyright © 2009-2017 Merck Sharp & Dohme Corp., a subsidiary of MSD & Co., Inc. All rights reserved.

This website is maintained by Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, New Jersey ("Merck") and is intended for use by individuals who are not residents of the U.S.

  • Forward-Looking Statement
  • Privacy
  • Terms of Use
Image: Circle Close Icon

Forward-Looking Statement ×
 

Forward-Looking Statement of MSD & Co., Inc., Kenilworth, NJ, USA

This website of MSD & Co., Inc., Kenilworth, NJ, USA (the “company”) includes “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. These statements are based upon the current beliefs and expectations of the company’s management and are subject to significant risks and uncertainties. There can be no guarantees with respect to pipeline products that the products will receive the necessary regulatory approvals or that they will prove to be commercially successful. If underlying assumptions prove inaccurate or risks or uncertainties materialize, actual results may differ materially from those set forth in the forward-looking statements.

Risks and uncertainties include, but are not limited to, general industry conditions and competition; general economic factors, including interest rate and currency exchange rate fluctuations; the impact of pharmaceutical industry regulation and healthcare legislation in the United States and internationally; global trends toward healthcare cost containment; technological advances, new products and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approval; the company’s ability to accurately predict future market conditions; manufacturing difficulties or delays; financial instability of international economies and sovereign risk; dependence on the effectiveness of the company’s patents and other protections for innovative products; and the exposure to litigation, including patent litigation, and/or regulatory actions.

The company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. Additional factors that could cause results to differ materially from those described in the forward-looking statements can be found in the company’s 2015 Annual Report on Form 10-K and the company’s other filings with the Securities and Exchange Commission (SEC) available at the SEC’s Internet site (www.sec.gov).

No Duty to Update

The information contained in this website was current as of the date presented. The company assumes no duty to update the information to reflect subsequent developments. Consequently, the company will not update the information contained in the website and investors should not rely upon the information as current or accurate after the presentation date.